DELIVERY IN A PATIENT WITH PREGNANCY INDUCED BY AN ASSISTED REPRODUCTIVE TECHNOLOGY (SURROGACY) PROGRAM AND WITH PLACENTA INCRETA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Placenta increta is a relevant problem of contemporary obstetrics. Over the past decade, the rate of this abnormality has increased by 50 times. The importance of the problem is increasing due to massive bleeding, in which the maternal mortality rate is as much as 7%. Placenta increta is one of the most severe abnormalities resulting from the partial or complete absence of the spongy layer of the decidua due to endometrial atrophic processes. Case report. The article describes a clinical case of a patient with pregnancy induced by an assisted reproductive technology (surrogacy) program and placenta increta. It describes in detail the mechanisms of pathogenesis, as well as delivery methods for abnormal placental invasion. Conclusion. The given clinical case is a demonstration of successfully applying a team approach during delivery in a woman with placenta increta: the introduction of current diagnostic and therapeutic blood-saving technologies and a surgical delivery method that does not require an additional uterine incision.

Full Text

Restricted Access

About the authors

Aleksandr V. SHAKLEIN

Maternity Hospital, City Clinical Hospital One

Email: a_shaklein@mail.ru
MD, Head of the Obstetric and Gynecological Service Novosibirsk, Russia

Alla N. DROBINSKAYA

Novosibirsk National Research State University

Email: drobinskayaa@mail.ru
PhD, Chief external resuscitator MOH NSO for childbirth, Head doctor of the Central City Hospital NSO Berdsk, Associate professor of the Department of Anesthesiology and Intensive Care NNRSU Novosibirsk, Russia

Sofya F. DELSUZ

Novosibirsk National Research State University

Email: delya_djal-side@mail.ru
Medical Resident Novosibirsk, Russia

Ilya M. DAVYDOV

Maternity Hospital, City Clinical Hospital One

Email: newlife_nsk@mail.ru
Head of Anesthesiology and Intensive Care №1, anesthesiologist-resuscitator of the highest qualification category Novosibirsk, Russia

Natalya M. PASMAN

Novosibirsk National Research State University; «Professor Pasman clinic» LLC

Email: nmpasman@gmail.com
MD, PhD, Professor, Obstetrician-gynecologist, Head of the Department of Obstetrics and Gynecology, NNRSU; Director of «Professor Pasman clinic» LLC. Novosibirsk, Russia

Anastasia A. STEPANOVA

Maternity Hospital, City Clinical Hospital One

Email: Ste3550@yandex.ru
PhD, Head of the Department of Obstetrics Pathology of Pregnant, obstetrician-gynecologist of the highest qualification category Novosibirsk, Russia

Aleksandra V. KOLESNIKOVA

Maternity Hospital, City Clinical Hospital One

Email: sasha_kol@mail.ru
obstetrician-gynecologist Novosibirsk, Russia

Evgeniya V. BYSTROVA

Maternity Hospital, City Clinical Hospital One

Email: bystrova.e.v@mail.ru
Head of the Postpartum Department, obstetrician-gynecologist Novosibirsk, Russia

References

  1. Ran Cui, Menghui Li, Junli Lu, Huimin Bai, Zhenyu Zhang. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study. BMC Pregnancy Childbirth. 2018; 18(1): 298. https://dx.doi.org/10.1186/s12884-018-1935-6.
  2. Thurn L., Lindqvist P.C., Jakobsson M., Colmorn L.B., KlungsoyrK., Bjarnadöttir R.I. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: Results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2015; 123(8): 1348-55. https://dx.doi. org/10.1111/1471-0528.13547.
  3. Silver R.M. Abnormal placentation: Placenta previa, vasa previa, and placenta accrete. Obstet. Gynecol. 2015; 126(3): 654-68. https://dx.doi.org/10.1097/ AOG.0000000000001005.
  4. Shmakov R.C., Vinitskiy A.A., Chuprinin V.D., Yarotskaya E.L., Sukhikh C.T. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J. Matern. Fetal Neonatal Med. 2019; 32(12): 2042-8. https://dx.doi.org/10.1080/14767058.2018.1424821.
  5. Kaser D.J., Melamed A., Bormann C.L., Myers D.E., Missmer S.A., Walsh B.W. et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil. Steril. 2015; 103(5): 1176-84. https://dx.doi.org/ 10.1016/j. fertnstert.2015.01.021.
  6. Jauniaux E., Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012; 33(4): 244-51. https://dx.doi. org/10.1016/j.placenta.2011.11.010.
  7. JauniauxE., Bhide A., Burton C.J. Pathophysiology of accreta. In: Silver R., ed. Placenta accrete syndrome. Portland: CRC Press. 2017: 13-28.
  8. Королев А.Ю., Пырегов А.В., Федорова Т.А., Шмаков Р.Г., Герасимов Ю.А., Шпилюк М.А., Медведева А.А. Безопасность регионарной анестезии при родоразрешении беременных с врастанием плаценты. Акушерство и гинекология. 2019; 1: 92-7.
  9. Шмаков Р.Г., Чупрынин В.Д., Кан Н.Е., Тютюнник В.Л., Виницкий А.А. Способ временной окклюзии общих подвздошных артерий при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2625286 26.09.2016.
  10. Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Способ двухуровнего гемостаза при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2626984 05.10.2016.
  11. Шмаков Р.Г., Чупрынин В.Д., Виницкий А.А. Комплексный компрессионный гемостаз при выполнении органосохраняющего оперативного родоразрешения у пациенток с врастанием плаценты. Патент на изобретение RUS 2627633 13.12.2016.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies